Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MNC Kapital Indonesia Tbk (BCAP) vs Prodia Widyahusada Tbk. (PRDA) Price & Performance

MNC Kapital Indonesia Tbk
Prodia Widyahusada Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

MNC Kapital Indonesia Tbk vs Prodia Widyahusada Tbk. — how do they compare? MNC Kapital Indonesia Tbk trades at Rp50 (market cap 2.13T, 136K 24h volume), while Prodia Widyahusada Tbk. trades at Rp2,390 (market cap 2.28T, 1.85M 24h volume). The key difference: MNC Kapital Indonesia Tbk and Prodia Widyahusada Tbk. are close in size by market cap, and Prodia Widyahusada Tbk. is more actively traded (1.85M versus 136K). Which is the better fit depends on your goals.

BCAPPRDA
Market Cap
2.13T2.28T
Volume
136K1.85M
Lot
1.36K18.49K
Turnover
6.8M4.44B
Average Price
502,402.77
Value
6.8M4.44B
Indicative Equilibrium Price
502,390
Indicative Equilibrium Volume
11.12K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BCAP
View details
PRDA
View details

About MNC Kapital Indonesia Tbk

PT MNC Kapital Indonesia Tbk formerly PT Bhakti Capital Indonesia Tbk was established on 15 July 1999, resulting from the restructuring and consolidation of PT Bhakti Investama Tbk, its holding company. At the time it was established, the Company commenced its business activities in the securities sector, among others are financial advisory, brokerage, underwriting, and research and development. In 2003, the Company carried out a business consolidation and transformed into a holding company of several subsidiaries that are engaged in financial services sector, namely PT Bhakti Finance, PT Bhakti Securities, and PT Bhakti Asset Management.

Read more on BCAP

About Prodia Widyahusada Tbk.

PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.

Read more on PRDA